Veru Inc. (VERU)

NASDAQ

$2.40

$-0.02

(-0.79%)

Pre-Market

Veru Inc. (VERU) Live Price Chart

Last updated: ⁦2026-10-13 09:20:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Veru Inc. (VERU) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.40, with a market capitalisation of $41.94M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.05 to $7.33. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$41.94M
Open	$2.42
Day's High	$245.70
Day's Low	$2.05
Previous Close	$2.40
Volume	54.00
Average Volume	233.37K
P/E Ratio	--
52-Week High	$7.33
52-Week Low	$2.05
Dividend Yield	--
Earnings Date	--

Veru Inc. (VERU) Pre-Market Stock Price

Veru Inc. (VERU) is trading at $2.40 in pre-market trading as of 2026-10-13 08:18:00, down 0.37% ($0.01) from the previous close of $2.41

Pre-market trading shows how investors are pricing VERU before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Veru Inc. (VERU) 7-Day Stock Price Change

Over the past seven days, Veru Inc. (VERU) moved from $2.51 to $2.40, representing a decline of 4.54% ($0.11).

The stock traded between $2.39 and $2.75 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 325.39 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

VERU 52-Week Price Position

Position in Range: 6.6%

52W Low$2.05

52W High$7.33

VERU is currently trading at $2.40, placing it 6.6% of the way from its 52-week low of $2.05 to its 52-week high of $7.33. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Veru Inc. (VERU)?

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

Veru Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	20
Exchange	NASDAQ
Company Website	https://www.verupharma.com

How to Buy Veru Inc. (VERU) Stock on MEXC

Eligible investors can buy real shares of Veru Inc. (VERU) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VERU and Place Your Order

Open the RealStocks trading page and search for VERU. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Veru Inc. (VERU) stock price today?

Veru Inc. (VERU) is currently trading at $ 2.40, down 0.37% ($0.01) from the previous close of $ 2.41. Intraday prices update in real time during regular trading hours.

2.Is VERU stock going up or down today?

As of 2026-10-13 08:18:00, VERU is trading at $ 2.40, down 0.37% ($0.01) from its previous close of $ 2.41. The stock has traded between $ 2.05 and $ 245.70 during today’s regular session. Past price movements do not guarantee future results.

3.What is VERU pre-market price?

As of 2026-10-13 08:18:00, VERU is trading at $ 2.40 in pre-market trading, down 0.37% ($0.01) from the previous close of $ 2.41. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VERU after-hours price?

As of 2026-10-13 08:18:00, VERU is trading at $ 2.42 in after-hours trading, up 0.42% ($0.01) from the regular-session close of $ 2.41. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VERU stock trading now?

VERU trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VERU sit relative to its 52-week high and low?

Over the past 52 weeks, VERU has traded between a low of $ 2.05 and a high of $ 7.33. At $ 2.40, the stock is positioned 6.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Veru Inc. in?

Veru Inc. (VERU) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Veru Inc.'s market capitalisation and where is it listed?

Veru Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 41.94M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VERU valued in terms of P/E ratio and EPS?

VERU trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.80. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Veru Inc. pay a dividend?

Veru Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.